Home > Analytics > VIVIMED LABS

VIVIMED LABS
Intrinsic Value | Fundamental Analysis

BOM : 532660     NSE : VIVIMEDLAB    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : Average [>25% and <50%]
Jun 24,2022
Price(EOD): β‚Ή 10.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 88.70 Cr
Value of β‚Ή 1 Lac invested in VIVIMED LABS
on Jun 27,2017 (price: β‚Ή 112.65)

β‚Ή 1 L

β‚Ή 0.09 L

1W : 27.1% 1M : -17.1% 1Y : -65.3%
COMMUNITY POLL
for VIVIMED LABS
Please provide your vote to see the results
VIVIMED LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
VIVIMED LABS 27.1% -17.1% -65.3%
SUN PHARMACEUTICAL INDUSTRIES 2.4% -8.5% 23.8%
DIVIS LABORATORIES 4.3% 6.7% -12.6%
DR REDDYS LABORATORIES 3.8% 0% -18.7%
CIPLA 0.8% -3.2% -2.4%
GLAND PHARMA 2.4% -7.3% -17.9%
PIRAMAL ENTERPRISES 3.9% -11% -33.4%
CADILA HEALTHCARE 5.7% -5.1% -45.1%
TORRENT PHARMACEUTICALS 4.1% -0.9% -2.5%

FUNDAMENTAL ANALYSIS OF VIVIMED LABS

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF VIVIMED LABS

 
Valuation Score
[As on : Jun 24,2022 ]

Ratio Consolidated
P/E
P/B
P/S
-
P/E Calculated based on EPS of -13.16
[ Mar2020 - Consolidated Results ]

0.19
P/B Calculated based on Book Value of 56.85
[ Mar2020 - Consolidated Results ]

0.37
P/S Calculated based on Revenues of 237.287 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF VIVIMED LABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
NA (-ve EV)
11%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF VIVIMED LABS


Insights πŸ’‘ There are 10% companies with bullish price momentum currently! Discover More →

VIVIMED LABS vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF VIVIMED LABS

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
-
0.59
0.65
0.41
-
1.18
1.05
0.74
[Last Annual Data : Mar2020]
Financial Ratios →

PLEDGED PROMOTER SHARES OF VIVIMED LABS

Pledged Promoter Shares
40.02 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF VIVIMED LABS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
8.16%
85.14%
34.48%
22.58%
56.78%
93.37%
44.39%
33.24%
QtrlyTrend
8
Latest Qtr: Mar2022
Quarterly Result Analysis →

Insights πŸ’‘ VIVIMEDLAB is one of the top 41% companies with good quarterly result uptrend ! Discover More →

VIVIMED LABS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about VIVIMED LABS


Is VIVIMED LABS good for long term investment?

As on Jun 24,2022, the Fundamentals of VIVIMED LABS look Poor and hence it may not be good for long term investment ! See Financial Performance of VIVIMED LABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is VIVIMED LABS UnderValued or OverValued?

As on Jun 24,2022, VIVIMED LABS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of VIVIMED LABS ?

As on Jun 24,2022, the Intrinsic Value of VIVIMED LABS is Rs. 9.63 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -10.24
Fair Value [Median EV / Sales Model] : Rs. -6.22
Fair Value [Median Price / Sales Model] : Rs. 9.63
Median Fair Value of VIVIMED LABS : Rs. 9.63

Is VIVIMED LABS trading at a Premium or Discount?

As on Jun 24,2022, VIVIMED LABS is trading at a Premium of 11% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z